Annual Current Liabilities
$17.08 M
+$5.53 M+47.91%
31 December 2023
Summary:
Cue Biopharma annual total current liabilities is currently $17.08 million, with the most recent change of +$5.53 million (+47.91%) on 31 December 2023. During the last 3 years, it has risen by +$765.00 thousand (+4.69%). CUE annual current liabilities is now at all-time high.CUE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$16.79 M
+$331.00 K+2.01%
30 September 2024
Summary:
Cue Biopharma quarterly total current liabilities is currently $16.79 million, with the most recent change of +$331.00 thousand (+2.01%) on 30 September 2024. Over the past year, it has dropped by -$417.00 thousand (-2.42%). CUE quarterly current liabilities is now -7.19% below its all-time high of $18.09 million, reached on 31 March 2024.CUE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +47.9% | -2.4% |
3 y3 years | +4.7% | +9.3% |
5 y5 years | +174.8% | +61.6% |
CUE Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +47.9% | -7.2% | +101.7% |
5 y | 5 years | at high | +174.8% | -7.2% | +101.7% |
alltime | all time | at high | +4891.5% | -7.2% | +1472.7% |
Cue Biopharma Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $16.79 M(+2.0%) |
June 2024 | - | $16.46 M(-9.0%) |
Mar 2024 | - | $18.09 M(+5.9%) |
Dec 2023 | $17.08 M(+47.9%) | $17.08 M(-0.7%) |
Sept 2023 | - | $17.21 M(+5.5%) |
June 2023 | - | $16.31 M(+18.1%) |
Mar 2023 | - | $13.81 M(+19.6%) |
Dec 2022 | $11.55 M(-9.7%) | $11.55 M(+13.0%) |
Sept 2022 | - | $10.22 M(+22.8%) |
June 2022 | - | $8.32 M(-27.1%) |
Mar 2022 | - | $11.41 M(-10.8%) |
Dec 2021 | $12.79 M(-21.6%) | $12.79 M(-16.7%) |
Sept 2021 | - | $15.36 M(-7.9%) |
June 2021 | - | $16.67 M(+0.2%) |
Mar 2021 | - | $16.63 M(+1.9%) |
Dec 2020 | $16.32 M | $16.32 M(+14.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $14.23 M(-4.3%) |
June 2020 | - | $14.86 M(+22.9%) |
Mar 2020 | - | $12.09 M(+3.7%) |
Dec 2019 | $11.66 M(+87.5%) | $11.66 M(+12.2%) |
Sept 2019 | - | $10.39 M(-7.8%) |
June 2019 | - | $11.27 M(+6.6%) |
Mar 2019 | - | $10.57 M(+70.1%) |
Dec 2018 | $6.22 M(+16.3%) | $6.22 M(+35.6%) |
Sept 2018 | - | $4.58 M(+54.7%) |
June 2018 | - | $2.96 M(-27.4%) |
Mar 2018 | - | $4.08 M(-23.6%) |
Dec 2017 | $5.35 M(+400.8%) | $5.35 M(+179.2%) |
Sept 2017 | - | $1.91 M(+21.2%) |
June 2017 | - | $1.58 M(+48.0%) |
Dec 2016 | $1.07 M(+212.0%) | $1.07 M |
Dec 2015 | $342.20 K | - |
FAQ
- What is Cue Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for Cue Biopharma?
- What is Cue Biopharma annual current liabilities year-on-year change?
- What is Cue Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cue Biopharma?
- What is Cue Biopharma quarterly current liabilities year-on-year change?
What is Cue Biopharma annual total current liabilities?
The current annual current liabilities of CUE is $17.08 M
What is the all time high annual current liabilities for Cue Biopharma?
Cue Biopharma all-time high annual total current liabilities is $17.08 M
What is Cue Biopharma annual current liabilities year-on-year change?
Over the past year, CUE annual total current liabilities has changed by +$5.53 M (+47.91%)
What is Cue Biopharma quarterly total current liabilities?
The current quarterly current liabilities of CUE is $16.79 M
What is the all time high quarterly current liabilities for Cue Biopharma?
Cue Biopharma all-time high quarterly total current liabilities is $18.09 M
What is Cue Biopharma quarterly current liabilities year-on-year change?
Over the past year, CUE quarterly total current liabilities has changed by -$417.00 K (-2.42%)